Page last updated: 2024-08-23

bostrycin and Lung Neoplasms

bostrycin has been researched along with Lung Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, WS; Guo, YB; Hou, JN; Lin, YC; She, ZG; Xie, CM; Yang, HL1

Other Studies

1 other study(ies) available for bostrycin and Lung Neoplasms

ArticleYear
Bostrycin inhibits proliferation of human lung carcinoma A549 cells via downregulation of the PI3K/Akt pathway.
    Journal of experimental & clinical cancer research : CR, 2011, Feb-08, Volume: 30

    Topics: Adenocarcinoma; Anthraquinones; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor Proteins; Down-Regulation; Humans; Lung Neoplasms; MicroRNAs; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction

2011